OPR - Delayed Quote USD

(VRTX160429C00075000)

9.00

0.00

(0.00%)

As of April 29 at 11:58 PM EDT. Market Open.

Loading Chart for VRTX160429C00075000

9/21 12:03 PM

DELL

Previous Close 9.00
Open 9.00
Bid 0.00
Ask 0.00
Strike 75.00
Expire Date 2016-04-29
Day's Range 9.00 - 9.00
Contract Range --
Volume 2
Open Interest --

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

Vertex begins bid for US approval of non-opioid painkiller

Vertex begins bid for US approval of non-opioid painkiller

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know

Vertex Pharma scientist talks about the long road to developing non-addictive painkillers

Vertex Pharma scientist talks about the long road to developing non-addictive painkillers

Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock

Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

3 Magnificent Stocks That Could Double or More by 2030

3 Magnificent Stocks That Could Double or More by 2030

Could This Stock Be the Next Biotech Buyout?

Could This Stock Be the Next Biotech Buyout?

Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex

Alpine (ALPN) Surges 37% on $4.9B Buyout Offer From Vertex

Health Care Roundup: Market Talk

Health Care Roundup: Market Talk

Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal

Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal